Curious about HealthEquity (HQY) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Analysts anticipate HealthEquity's (HQY) upcoming earnings to show a 1.3% year-over-year EPS increase to $0.81 and an 11.7% revenue increase to $321.13 million; however, the consensus EPS estimate has been revised 0.2% lower in the last 30 days. Key metrics projections include 'Revenue- Custodial' at $151.45 million (+24.5% YOY) and 'Total HSA Assets' reaching $32.13 billion, up from $27.28 billion in the same quarter last year. HealthEquity shares have outperformed the S&P 500 over the past month, and the stock currently holds a Zacks Rank #2 (Buy).

Analysis

Wall Street analysts project HealthEquity (HQY) to report a 1.3% year-over-year increase in quarterly earnings per share to $0.81 and an 11.7% rise in revenues to $321.13 million for its upcoming report. This anticipated revenue growth is notably driven by a strong projected 24.5% YoY increase in 'Revenue- Custodial' to $151.45 million, alongside more modest growth in 'Revenue- Service' (+0.8% YoY to $119.18 million) and 'Revenue- Interchange' (+4.1% YoY to $49.71 million). A key indicator of HealthEquity's underlying business strength is the expected growth in 'Total HSA Assets' to $32.13 billion, up from $27.28 billion in the prior year, and a rise in 'HSAs Accounts' to 10.05 million from 9.1 million. Similarly, 'Total HSA investments' are forecast to reach $14.46 billion, compared to $11.43 billion a year ago, and 'Total Accounts' are expected to increase to 16.92 million from 16.01 million. Despite these positive trends, the consensus EPS estimate has seen a slight downward revision of 0.2% over the last 30 days, and 'CDBs Accounts' are projected to slightly decrease to 6.86 million from 6.91 million year-over-year. The company's shares have demonstrated strong recent performance, returning +18.4% over the past month, significantly outpacing the S&P 500 composite's +6.7% change, and currently holds a Zacks Rank #2 (Buy), suggesting potential for continued outperformance.

Key Decisions for Investors

• Consider the positive outlook driven by significant growth in HSA assets and custodial revenue, supported by a Zacks #2 (Buy) rating and recent market outperformance, when evaluating positions in HQY.
• Closely scrutinize the upcoming earnings report for confirmation of the projected 24.5% YoY growth in 'Revenue- Custodial' and the increase in 'HSAs Accounts' to 10.05 million, as these are critical to the investment thesis.
• Pay attention to the actual EPS relative to the revised $0.81 estimate and the performance of 'CDBs Accounts', which are expected to see a slight decline, to gauge the full health of the business and potential market reaction.